-
-
Small Molecule Drug Platform
-
Chiral Catalysis Technology
-
Continuous Flow Technology
-
Fluorine Chemistry
-
Enzyme Catalysis
-
Photocatalysis
-
Solid-State Research
显示更多 -
-
Drug Product (DP) Platforms
-
Sustained and Controlled Release
-
Solubility Enhancement
-
Topical Formulation
-
Liquid Formulation
-
Softgels
-
Flow-through cell
显示更多 -
-
Peptide Platform
显示更多 -
Research Team
显示更多
-
![](/npublic/img/s.png)
Jiuzhou Pharma First Selected into the FTSE4Good Index Series
Recently, FTSE Russell (the trading name of FTSE International Limited and Frank Russell Company) confirms that Zhejiang Jiuzhou Pharmaceutical Co., Ltd.
2024-07-15
Recently, Jiuzhou Pharmaceutical has officially joined the United Nations Global Compact (UNGC)
2024-07-08
On July 1st, the commissioning ceremony of Jiuzhou Pharmaceutical (Taizhou) Co., Ltd. was held in Taizhou Bay Economic Development Zone.
2024-07-01
1月19日晚,浙江经济界年度盛典——2023年度风云浙商颁奖仪式在杭州隆重举行。十位年度风云浙商、一个年度风云浙商群体正式揭晓。九洲药业董事长花莉蓉荣登“2023年度风云浙商”。浙江省委宣传部副部长、省政府新闻办主任虞汉胤为花莉蓉颁奖。
2024-01-22
2024-06-24
2024-06-20
2024-01-22
2023-11-09
2023-11-09
2023-11-09
2023-11-09
Business Collaboration
Innovative Drug CDMO Services
![Zhejiang Jiuzhou Pharmaceutical Co., Ltd. Zhejiang Jiuzhou Pharmaceutical Co., Ltd.](https://omo-oss-image.thefastimg.com/portal-saas/new2023050917060170378/cms/image/af9820f2-7496-4bb9-a939-cbf57718f448.jpg)